Unusual Tumors of the Temporal Bone

Chapter

Abstract

This chapter discusses rare tumors of the temporal bone. While squamous cell carcinoma is the most common tumor to affect the temporal bone, other rare tumors are recognized. These tumor types include endolymphatic sac tumors, giant-cell tumor, and hemangiopericytoma. These tumors have unique characteristics and are individually discussed. Endolymphatic sac tumors and hemangiopericytomas are highly vascular tumors that often require preoperative embolization. Complete surgical excision is treatment of choice but is often difficult to achieve given the anatomy of the temporal bone. Radiotherapy offers reasonable local control in the postoperative setting when residual tumor remains.

Keywords

Endolymphatic sac tumor von Hippel-Lindau syndrome  Papillary adenocarcinoma Giant-cell tumor Hemangiopericytoma Solitary fibrous tumor 

References

  1. 1.
    Duderstadt M, Forster C, Welkoborsky HJ, Ostertag H. Adenomatous tumors of the middle ear and temporal bone: clinical, morphological and tumor biological characteristics of challenging neoplastic lesions. Eur Arch Otorhinolaryngol. 2012;269(3):823–31.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Kempermann G, Neumann H, Volk B. Endolymphatic sac tumours. Histopathology. 1998;33(1):2–10.PubMedGoogle Scholar
  3. 3.
    Brandt R. Zur Frage der Angiomatosis retinae. Graefes Arch Clin Exp Ophthalmol. 1921;106(1):127–65.Google Scholar
  4. 4.
    Hassard A, Boudreau S, Cron C. Adenoma of the endolymphatic sac. J Otolaryngol. 1984;13(4):213.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Gaffey MJ, Mills SE, Fechner RE, Intemann SR, Wick MR. Aggressive papillary middle-ear tumor: a clinicopathologic entity distinct from middle-ear adenoma. Am J Surg Pathol. 1988;12(10):790–4.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Heffner DK. Low-grade adenocarcinoma of probable endolymphatic sac origin a clinicopathologic study of 20 cases. Cancer. 1989;64(11):2292–302.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Li JC, Brackmann DE, Lo WW, Carberry JN, House JW. Reclassification of aggressive adenomatous mastoid neoplasms as endolymphatic sac tumors. Laryngoscope. 1993;103(12):1342–8.PubMedGoogle Scholar
  8. 8.
    Batsakis JG, El-Naggar AK. Papillary neoplasms (Heffner’s tumors) of the endolymphatic sac. Ann Otol Rhinol Laryngol. 1993;102(8 Pt 1):648–51.PubMedGoogle Scholar
  9. 9.
    von Hippel E. Vorstellung eines Patienten mit einer sehr ungenwohnlichen Netzhaut. Wiesbaden: XXIV Verstellung der ophthalmologischen Gesellschaft. JF Bergman; 1896.Google Scholar
  10. 10.
    Bausch B, Wellner U, Peyre M, Boedeker CC, Hes FJ, Anglani M, et al. Characterization of endolymphatic sac tumors and von Hippel-Lindau disease in the International Endolymphatic Sac Tumor Registry. Head Neck. 2016;38(Suppl 1):E673–9.  https://doi.org/10.1002/hed.24067.CrossRefPubMedGoogle Scholar
  11. 11.
    Latif F, Tory K, Gnarra J, Yao M, Duh F-M, Orcutt ML, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 1993;260:1317.PubMedGoogle Scholar
  12. 12.
    Hamazaki S, Yoshida M, Yao M, Nagashima Y, Taguchi K, Nakashima H, et al. Mutation of von Hippel-Lindau tumor suppressor gene in a sporadic endolymphatic sac tumor. Hum Pathol. 2001;32(11):1272–6.PubMedGoogle Scholar
  13. 13.
    Kawahara N, Kume H, Ueki K, Mishima K, Sasaki T, Kirino T. VHL gene inactivation in an endolymphatic sac tumor associated with von Hippel-Lindau disease. Neurology. 1999;53(1):208–10.PubMedGoogle Scholar
  14. 14.
    Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci. 1971;68(4):820–3.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM, et al. von Hippel-Lindau disease. Lancet. 2003;361(9374):2059–67.PubMedGoogle Scholar
  16. 16.
    Gaffey MJ, Mills SE, Boyd JC. Aggressive papillary tumor of middle ear/temporal bone and adnexal papillary cystadenoma. Manifestations of von Hippel-Lindau disease. Am J Surg Pathol. 1994;18(12):1254–60.PubMedPubMedCentralGoogle Scholar
  17. 17.
    Kunzel J, Agaimy A, Hornung J, Lell M, Ganslandt O, Semrau S, et al. Sporadic endolymphatic sac tumor—a diagnostic and therapeutic challenge. Int J Clin Exp Pathol. 2014;7(5):2641–6.PubMedPubMedCentralGoogle Scholar
  18. 18.
    Poulsen MLM, Gimsing S, Kosteljanetz M, Møller HU, Brandt CA, Thomsen C, et al. Von Hippel-Lindau disease: surveillance strategy for endolymphatic sac tumors. Genet Med. 2011;13(12):1032–41.PubMedGoogle Scholar
  19. 19.
    Lonser RR, Kim HJ, Butman JA, Vortmeyer AO, Choo DI, Oldfield EH. Tumors of the endolymphatic sac in von Hippel-Lindau disease. N Engl J Med. 2004;350(24):2481–6.PubMedGoogle Scholar
  20. 20.
    Manski TJ, Heffner DK, Glenn GM, Patronas NJ, Pikus AT, Katz D, et al. Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease. JAMA. 1997;277(18):1461–6.PubMedGoogle Scholar
  21. 21.
    Choo D, Shotland L, Mastroianni M, Glenn G, Cv W, Linehan WM, et al. Endolymphatic sac tumors in von Hippel—Lindau disease. J Neurosurg. 2004;100(3):480–7.PubMedGoogle Scholar
  22. 22.
    Eby TL, Makek MS, Fisch U. Adenomas of the temporal bone. Ann Otol Rhinol Laryngol. 1988;97(6 Pt 1):605–12.PubMedGoogle Scholar
  23. 23.
    Megerian CA, McKenna MJ, Nuss RC, Maniglia AJ, Ojemann RG, Pilch BZ, et al. Endolymphatic sac tumors: histopathologic confirmation, clinical characterization, and implication in von Hippel-Lindau disease. Laryngoscope. 1995;105(8 Pt 1):801–8.PubMedGoogle Scholar
  24. 24.
    Poe DS, Tarlov EC, Thomas CB, Kveton JF. Aggressive papillary tumors of temporal bone. Otolaryngol Head Neck Surg. 1993;108(1):80–6.PubMedGoogle Scholar
  25. 25.
    Noel FL, Benecke JE Jr, Carberry JN, House JW, Patterson M. Adenomas of the mastoid and middle ear. Otolaryngol Head Neck Surg. 1991;104(1):133–4.PubMedGoogle Scholar
  26. 26.
    Kim HJ, Butman JA, Brewer C, Zalewski C, Vortmeyer AO, Glenn G, et al. Tumors of the endolymphatic sac in patients with von Hippel-Lindau disease: implications for their natural history, diagnosis, and treatment. J Neurosurg. 2005;102(3):503–12.PubMedGoogle Scholar
  27. 27.
  28. 28.
    Bambakidis NC, Megerian CA, Ratcheson RA. Differential grading of endolymphatic sac tumor extension by virtue of von Hippel-Lindau disease status. Otol Neurotol. 2004;25(5):773–81.PubMedPubMedCentralGoogle Scholar
  29. 29.
    Kupferman ME, Bigelow DC, Carpentieri DF, Bilaniuk LT, Kazahaya K. Endolymphatic sac tumor in a 4-year-old boy. Otol Neurotol. 2004;25(5):782–6.PubMedGoogle Scholar
  30. 30.
    Bambakidis NC, Rodrigue T, Megerian CA, Ratcheson RA. Endolymphatic sac tumor metastatic to the spine. Case report. J Neurosurg Spine. 2005;3(1):68–70.PubMedPubMedCentralGoogle Scholar
  31. 31.
    Reijneveld J, Hanlo P, Groenewoud G, Jansen G, van Overbeeke K, Tulleken C. Endolymphatic sac tumor: a case report and review of the literature. Surg Neurol. 1997;48(4):368–73.PubMedGoogle Scholar
  32. 32.
    Carlson ML, Thom JJ, Driscoll CL, Haynes DS, Neff BA, Link MJ, et al. Management of primary and recurrent endolymphatic sac tumors. Otol Neurotol. 2013;34(5):939–43.PubMedGoogle Scholar
  33. 33.
    Butman JA, Kim HJ, Baggenstos M, Ammerman JM, Dambrosia J, Patsalides A, et al. Mechanisms of morbid hearing loss associated with tumors of the endolymphatic sac in von Hippel-Lindau disease. JAMA. 2007;298(1):41–8.PubMedGoogle Scholar
  34. 34.
    Lee KJ, Kirsch CF, Lai C, Ishiyama A. Endolymphatic sac tumor presenting with Ménière’s disease. Otolaryngol Head Neck Surg. 2010;142(6):915–6.PubMedGoogle Scholar
  35. 35.
    Ong YK, Chee NW, Hwang PY, Goh J. Endolymphatic sac tumour: a rare cause of recurrent vertigo. Singapore Med J. 2006;47(7):627–30.PubMedGoogle Scholar
  36. 36.
    Hansen MR, Luxford WM. Surgical outcomes in patients with endolymphatic sac tumors. Laryngoscope. 2004;114(8):1470–4.PubMedGoogle Scholar
  37. 37.
    Timmer FC, Neeskens LJ, Van De Hoogen FJ, Slootweg PJ, Dunnebier EA, Pauw BH, et al. Endolymphatic sac tumors: clinical outcome and management in a series of 9 cases. Otol Neurotol. 2011;32(4):680–5.PubMedGoogle Scholar
  38. 38.
    Poletti AM, Dubey SP, Barbo R, Pericotti S, Fiamengo B, Colombo G, et al. Sporadic endolymphatic sac tumor: its clinical, radiological, and histological features, management, and follow-up. Head Neck. 2013;35(7):1043–7.PubMedGoogle Scholar
  39. 39.
    Patel NP, Wiggins RH 3rd, Shelton C. The radiologic diagnosis of endolymphatic sac tumors. Laryngoscope. 2006;116(1):40–6.PubMedGoogle Scholar
  40. 40.
    Ho VT, Rao VM, Doan HT, Mikaelian DO. Low-grade adenocarcinoma of probable endolymphatic sac origin: CT and MR appearance. AJNR Am J Neuroradiol. 1996;17(1):168–70.PubMedGoogle Scholar
  41. 41.
    Mukherji SK, Albernaz VS, Lo WW, Gaffey MJ, Megerian CA, Feghali JG, et al. Papillary endolymphatic sac tumors: CT, MR imaging, and angiographic findings in 20 patients. Radiology. 1997;202(3):801–8.PubMedGoogle Scholar
  42. 42.
    Al-Anazi AR, Holliday W, Sheikh B, Gentili F. Extraosseous endolymphatic sac low-grade adenocarcinoma mimicking posterior fossa meningioma. J Neurosurg. 2001;95(5):893–6.PubMedGoogle Scholar
  43. 43.
    Binderup ML, Gimsing S, Kosteljanetz M, Thomsen C, Bisgaard ML. von Hippel-Lindau disease: deafness due to a non-MRI-visible endolymphatic sac tumor despite targeted screening. Int J Audiol. 2013;52(11):771–5.PubMedGoogle Scholar
  44. 44.
    Eze N, Huber A, Schuknecht B. De novo development and progression of endolymphatic sac tumour in von Hippel-Lindau disease: an observational study and literature review. J Neurol Surg B Skull Base. 2013;74(5):259–65.PubMedPubMedCentralGoogle Scholar
  45. 45.
    Lo WW, Applegate LJ, Carberry JN, Solti-Bohman LG, House JW, Brackmann DE, et al. Endolymphatic sac tumors: radiologic appearance. Radiology. 1993;189(1):199–204.PubMedGoogle Scholar
  46. 46.
    Schipper J, Maier W, Rosahl S, Berlis A, Laszig R. Tumour staged surgery of endolymphatic sac tumors (ELST). Laryngorhinootologie. 2004;83(8):493–500.PubMedGoogle Scholar
  47. 47.
    Megerian CA, Haynes DS, Poe DS, Choo DI, Keriakas TJ, Glasscock Iii ME. Hearing preservation surgery for small endolymphatic sac tumors in patients with von Hippel-Lindau syndrome. Otol Neurotol. 2002;23(3):378–87.PubMedGoogle Scholar
  48. 48.
    Rodrigues S, Fagan P, Turner J. Endolymphatic sac tumors: a review of the St. Vincent’s hospital experience. Otol Neurotol. 2004;25(4):599–603.PubMedGoogle Scholar
  49. 49.
    SJ Y, Chen YD, Gao F, Qiu XG, Chang H. Endolymphatic sac papillary tumor: a case report. Chin Med J (Engl). 2011;124(22):3828–9.Google Scholar
  50. 50.
    Gupta R, Vaidhyswaran AN, Murali V, Kameswaran M. Endolymphatic sac papillary carcinoma treated with surgery and post-operative intensity-modulated radiotherapy: a rare case report. J Cancer Res Ther. 2010;6(4):540–2.PubMedGoogle Scholar
  51. 51.
    Balasubramaniam S, Deshpande RB, Misra BK. Gamma knife radiosurgery in jugular foramen endolymphatic sac adenocarcinoma. J Clin Neurosci. 2009;16(5):710–1.PubMedGoogle Scholar
  52. 52.
    Virk JS, Randhawa PS, Saeed SR. Endolymphatic sac tumour: case report and literature review. J Laryngol Otol. 2013;127(4):408–10.PubMedGoogle Scholar
  53. 53.
    Ferreira MA, Feiz-Erfan I, Zabramski JM, Spetzler RF, Coons SW, Preul MC. Endolymphatic sac tumor: unique features of two cases and review of the literature. Acta Neurochir. 2002;144(10):1047–53.PubMedGoogle Scholar
  54. 54.
    Guha D, Menard C, Evans W, Gentili F, Zadeh G. Flap reconstruction and hyperbaric oxygen therapy in the management of temporal bone osteoradionecrosis in an endolymphatic sac tumor: case report. Skull Base Rep. 2011;1(2):125–8.PubMedPubMedCentralGoogle Scholar
  55. 55.
    Byun JH, Park KB, Ko JS, Ahn SK. Giant cell tumor of Infratemporal fossa and mandibular condyle: a case report. J Int Adv Otol. 2015;11(1):88–91.PubMedGoogle Scholar
  56. 56.
    Kinney SE, Wood BG. Malignancies of the external ear canal and temporal bone: surgical techniques and results. Laryngoscope. 1987;97(2):158-64.PubMedGoogle Scholar
  57. 57.
    Germano A, Caruso G, Caffo M, Galatioto S, Belvedere M, Cardia E. Temporal osteoclastoma: an exceptional lesion in infancy. Childs Nerv Syst. 1998;14(4–5):213–7.PubMedGoogle Scholar
  58. 58.
    Akyigit A, Karlidag T, Sakallioglu O, Polat C, Keles E. Giant cell tumor of bone involving the temporomandibular joint and temporal bone. J Craniofac Surg. 2014;25(4):1397–9.PubMedGoogle Scholar
  59. 59.
    ZH L, Yao ZW. Giant cell tumour of the posterior cranial fossa: a case report. Br J Radiol. 2011;84(1007):e206–9.Google Scholar
  60. 60.
    Zhang Z, Xu J, Yao Y, Chu S, Cheng H, Chen D, et al. Giant cell tumors of the skull: a series of 18 cases and review of the literature. J Neurooncol. 2013;115(3):437–44.PubMedGoogle Scholar
  61. 61.
    Rosenbloom JS, Storper IS, Aviv JE, Hacein-Bey L, Bruce JN. Giant cell tumors of the jugular foramen. Am J Otolaryngol. 1999;20(3):176–9.PubMedGoogle Scholar
  62. 62.
    Roberts DS, Faquin WC, Deschler DG. Temporal bone giant cell tumour: report of a second primary giant cell tumour of the temporal bone and infratemporal fossa. B-ENT. 2011;7(4):301–3.PubMedGoogle Scholar
  63. 63.
    Ong HS, Zhang CP, YQ W, Ji T. Update on the surgical management of temporomandibular joint-centered tendon sheath giant cell tumor with intradural extension: introducing a cost-effective method in using temporal bone for skull base reconstruction in preventing brain hernia. J Craniofac Surg. 2014;25(5):1769–72.PubMedGoogle Scholar
  64. 64.
    Wang Y, Honda K, Suzuki S, Ishikawa K. Giant cell tumor at the lateral skull base. Am J Otolaryngol. 2006;27(1):64–7.PubMedGoogle Scholar
  65. 65.
    Caudell JJ, Ballo MT, Zagars GK, Lewis VO, Weber KL, Lin PP, et al. Radiotherapy in the management of giant cell tumor of bone. Int J Radiat Oncol Biol Phys. 2003;57(1):158–65.PubMedGoogle Scholar
  66. 66.
    Elder JB, Berry C, Gonzalez-Gomez I, Kreger MD, McComb JG. Giant cell tumor of the skull in pediatric patients. Report of two cases. J Neurosurg. 2007;107(1 Suppl):69–74.PubMedGoogle Scholar
  67. 67.
    Dinning TA. Osteoclastoma of the petrous temporal bone; report of a case benefited by deep x-ray therapy. Aust N Z J Surg. 1953;22(4):253–7.PubMedGoogle Scholar
  68. 68.
    Pina S, Fernandez M, Maya S, Garcia RA, Noor A, Pawha PS, et al. Recurrent temporal bone tenosynovial giant cell tumor with chondroid metaplasia: the use of imaging to assess recurrence. Neuroradiol J. 2014;27(1):97–101.PubMedPubMedCentralGoogle Scholar
  69. 69.
    Cui Y, Zong XY, Hao SY, Zhang YZ. Microsurgical treatment of giant cell tumor of skull. Zhonghua Yi Xue Za Zhi. 2010;90(23):1622–4.PubMedGoogle Scholar
  70. 70.
    Liu J, Yang H, Sun R, Yang Z, Zhu Z. Retrospective analysis of patients with rare-site and metastatic giant cell tumor. Chin J Cancer Res. 2013;25(5):585–92.PubMedPubMedCentralGoogle Scholar
  71. 71.
    Bibas-Bonet H, Fauze RA, Lavado MG, Paez RO, Nieman J. Garcin syndrome resulting from a giant cell tumor of the skull base in a child. Pediatr Neurol. 2003;28(5):392–5.PubMedGoogle Scholar
  72. 72.
    Prasad SC, Piccirillo E, Nuseir A, Sequino G, De Donato G, Paties CT, et al. Giant cell tumors of the skull base: case series and current concepts. Audiol Neurootol. 2014;19(1):12–21.PubMedGoogle Scholar
  73. 73.
    Lee HJ, Lum C. Giant-cell tumor of the skull base. Neuroradiology. 1999;41(4):305–7.PubMedGoogle Scholar
  74. 74.
    Jain S, Sam A, Yohannan DI, Kumar S, Joshi D, Kumar A. Giant cell tumor of the temporal bone—an unusual presentation. Clin Neurol Neurosurg. 2013;115(5):646–8.PubMedGoogle Scholar
  75. 75.
    Tang JY, Wang CK, Su YC, Yang SF, Huang MY, Huang CJ. MRI appearance of giant cell tumor of the lateral skull base: a case report. Clin Imaging. 2003;27(1):27–30.PubMedGoogle Scholar
  76. 76.
    Borges BB, Fornazieri MA, Bezerra AP, Martins LA, Pinna Fde R, Voegels RL. Giant cell bone lesions in the craniofacial region: a diagnostic and therapeutic challenge. Int Forum Allergy Rhinol. 2012;2(6):501–6.PubMedGoogle Scholar
  77. 77.
    Ashamallah RS. Osteoclastoma of the petrous temporal bone. J Laryngol Otol. 1978;92(10):905–9.PubMedGoogle Scholar
  78. 78.
    Buter JJ, Chilla R. Giant cell tumor of the temporal bone (osteoclastoma). Eur Arch Otorhinolaryngol. 1997;254(6):298–300.PubMedGoogle Scholar
  79. 79.
    Fisher M, Biddinger P, Folpe AL, McKinnon B. Chondroid tenosynovial giant cell tumor of the temporal bone. Otol Neurotol. 2013;34(6):e49–50.PubMedGoogle Scholar
  80. 80.
    Takata Y, Hidaka H, Ishida K, Kobayashi T. Giant cell reparative granuloma of the temporal bone successfully resected with preservation of hearing. J Laryngol Otol. 2013;127(7):716–20.PubMedGoogle Scholar
  81. 81.
    Lee MY, Lee EJ. Giant cell tumor of the petrous temporal bone with direct invasion into the middle ear. J Craniofac Surg. 2006;17(4):797–800.PubMedGoogle Scholar
  82. 82.
    Guerrissi JO, Miranda MG, Olivier R. Giant hemangiopericytoma of mandible: a propos of a case: a variant of the surgical technique for protection of the articular fosse. J Craniofac Surg. 2006;17(3):523–7.PubMedGoogle Scholar
  83. 83.
    Brucoli M, Giarda M, Valente G, Benech A. Hemangiopericytoma of the infratemporal fossa: progression toward malignancy in a 30-year history. J Craniofac Surg. 2005;16(6):1146–50.PubMedGoogle Scholar
  84. 84.
    Bianchi B, Poli T, Bertolini F, Sesenna E. Malignant hemangiopericytoma of the infratemporal fossa: report of a case. J Oral Maxillofac Surg. 2002;60(3):309–12.PubMedGoogle Scholar
  85. 85.
    Birzgalis AR, Ramsden RT, Lye RH, Richardson PL. Haemangiopericytoma of the temporal bone. J Laryngol Otol. 1990;104(12):998–1003.PubMedGoogle Scholar
  86. 86.
    Shi ZP, Lin YS, Lin CK, Chen HC, Wang CH. Multiple metastatic progression of meningeal hemangiopericytoma initially diagnosed as atypical meningioma with temporal bone invasion. Otolaryngol Head Neck Surg. 2009;140(2):278–80.PubMedGoogle Scholar
  87. 87.
    Hornoy P, Sonigo P, Fallet-Bianco C, Largiliere P, Teillac D, Gomes H, et al. Fetal hemangiopericytoma with an associated cerebral anomaly. Ultrasound Obstet Gynecol. 2005;26(1):81–5.PubMedGoogle Scholar
  88. 88.
    Tewfik TL, Finlayson M, Attia EL. Hemangiopericytoma of the temporal bone. J Otolaryngol. 1981;10(1):72–7.Google Scholar
  89. 89.
    Schick B, Brors D, Draf W. Experiences with hemangiopericytoma in cranial base surgery. Laryngorhinootologie. 1998;77(5):256–63.PubMedGoogle Scholar
  90. 90.
    Cross DL, Mixon C. Temporal bone hemangiopericytoma. Otolaryngol Head Neck Surg. 1996;114(4):631.PubMedPubMedCentralGoogle Scholar
  91. 91.
    Magliulo G, Terranova G, Cordeschi S. Hemangiopericytoma and temporal bone. An Otorrinolaringol Ibero Am. 1999;26(1):67–74.PubMedGoogle Scholar
  92. 92.
    Megerian CA, McKenna MJ, Nadol JB Jr. Non-paraganglioma jugular foramen lesions masquerading as glomus jugulare tumors. Am J Otol. 1995;16(1):94–8.Google Scholar
  93. 93.
    Chin LS, Rabb CH, Hinton DR, Apuzzo ML. Hemangiopericytoma of the temporal bone presenting as a retroauricular mass. Neurosurgery. 1993;33(4):728–31; discussion 31–2.PubMedPubMedCentralGoogle Scholar
  94. 94.
    Chlangani D, Saxena R, Popli S, Bharadwaj T. Hemangiopericytoma of the postauricular region. J Laryngol Otol. 1970;84:457–61.Google Scholar
  95. 95.
    Weber AL, McKenna MJ. Radiologic evaluation of the jugular foramen. Anatomy, vascular variants, anomalies, and tumors. Neuroimaging Clin N Am. 1994;4(3):579–98.PubMedPubMedCentralGoogle Scholar
  96. 96.
    Tashjian VS, Khanlou N, Vinters HV, Canalis RF, Becker DP. Hemangiopericytoma of the cerebellopontine angle: a case report and review of the literature. Surg Neurol. 2009;72(3):290–5.PubMedGoogle Scholar
  97. 97.
    Sade B, Budur K, Lee DK, Franco K, Lee JH. Major depression with psychosis after resection of a giant middle fossa hemangiopericytoma. Surg Neurol. 2006;65(3):290–2; discussion 2.PubMedGoogle Scholar
  98. 98.
    Stout AP, Murray MR. Hemangiopericytoma: a vascular tumor featuring Zimmermann’s pericytes. Ann Surg. 1942;116(1):26.PubMedPubMedCentralGoogle Scholar
  99. 99.
    Thway K, Ng W, Noujaim J, Jones RL, Fisher C. The current status of solitary fibrous tumor: diagnostic features, variants, and genetics. Int J Surg Pathol. 2016;24(4):281–92.PubMedGoogle Scholar
  100. 100.
    Zhou JL, Liu JL, Zhang J, Zhang M. Thirty-nine cases of intracranial hemangiopericytoma and anaplastic hemangiopericytoma: a retrospective review of MRI features and pathological findings. Eur J Radiol. 2012;81(11):3504–10.PubMedGoogle Scholar
  101. 101.
    Rutkowski MJ, Jian BJ, Bloch O, Chen C, Sughrue ME, Tihan T, et al. Intracranial hemangiopericytoma. Cancer. 2012;118(6):1628–36.PubMedGoogle Scholar
  102. 102.
    Sonabend AM, Zacharia BE, Goldstein H, Bruce SS, Hershman D, Neugut AI, et al. The role for adjuvant radiotherapy in the treatment of hemangiopericytoma: a surveillance, epidemiology, and end results analysis: clinical article. J Neurosurg. 2014;120(2):300–8.PubMedGoogle Scholar
  103. 103.
    Spina A, Boari N, Gagliardi F, Donofrio CA, Franzin A, Mortini P. The current role of gamma knife radiosurgery in the management of intracranial haemangiopericytoma. Acta Neurochir. 2016;158(4):635–42.PubMedGoogle Scholar
  104. 104.
    Dufour H, Métellus P, Fuentes S, Murracciole X, Régis J, Figarella-Branger D, et al. Meningeal hemangiopericytoma: a retrospective study of 21 patients with special review of postoperative external radiotherapy. Neurosurgery. 2001;48(4):756–63.PubMedGoogle Scholar
  105. 105.
    Soyuer S, Chang EL, Selek U, McCutcheon IE, Maor MH. Intracranial meningeal hemangiopericytoma: the role of radiotherapy. Cancer. 2004;100(7):1491–7.PubMedGoogle Scholar
  106. 106.
    Melone AG, D’Elia A, Santoro F, Salvati M, Delfini R, Cantore G, et al. Intracranial hemangiopericytoma—our experience in 30 years: a series of 43 cases and review of the literature. World Neurosurg. 2014;81(3):556–62.PubMedGoogle Scholar
  107. 107.
    Guthrie BL, Ebersold MJ, Scheithauer BW, Shaw EG. Meningeal hemangiopericytoma: histopathological features, treatment, and long-term follow-up of 44 cases. Neurosurgery. 1989;25(4):514–22.PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Head and Neck SurgeryThe University of Texas M.D. Anderson Cancer CenterHoustonUSA

Personalised recommendations